Home Management of Adult Egyptian Mild COVID-19 Cases

NCT04515199 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-08-17

No results posted yet for this study

Summary

Keeping in mind the rising number of cases in Egypt and the strain they put on hospital infrastructure, the idea of home isolation and follow up for COVID 19 positive cases has been adopted in many countries and was approved by World Health Organization (WHO) and Egyptian Ministry of health (MOH).

Telehealth can help to mitigate this risk by minimizing the amount of face-to-face interactions. The WHO mentioned telemedicine among essential services in "strengthening the Health Systems Response to COVID-19" policy. The aim in this study is to study the effectiveness of telemedicine in managing mild COVID cases regarding isolation measures, symptoms, medications adherence, and reporting of red flags and side effects.

Conditions

  • Covid19
  • Telemedicine
  • Quality of Life
  • Safety Issues
  • Symptoms

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ibrahim El Ebrashy, Professor · Internal Medicine Department, Faculty of Medicine, Cairo University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2021-01-31
Completion
2021-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04515199 on ClinicalTrials.gov